Angiodynamics (ANGO) Free Cash Flow (2010 - 2026)

Angiodynamics' Free Cash Flow history runs 17 years deep, the most recent figure standing at $17.0 million for Q2 2026.

• Quarterly Free Cash Flow fell 5.52% year-over-year to $17.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $508000.0 (up 103.48% YoY) and the FY2026 annual result came in at $508000.0, up 103.48% from the prior year.
• Free Cash Flow was $17.0 million for Q2 2026 at Angiodynamics, up from -$4.1 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $18.0 million in Q2 2025 and bottomed at -$27.0 million in Q3 2022.
• A 5-year average of -$2.8 million and a median of -$76500.0 in 2023 frame the typical range for Free Cash Flow.
• Peak annual rise in Free Cash Flow reached 842.72% in 2022, while the deepest fall reached 858.97% in 2022.
• Angiodynamics' Free Cash Flow stood at $7.6 million in 2022, then tumbled by 38.61% to $4.7 million in 2023, then sank by 72.08% to $1.3 million in 2024, then jumped by 223.83% to $4.2 million in 2025, then soared by 301.96% to $17.0 million in 2026.
• Business Quant data shows ANGO's Free Cash Flow at $17.0 million in Q2 2026, -$4.1 million in Q1 2026, and $4.2 million in Q4 2025.